W. L. Gore & Associates, Inc.: FDA filings under this applicant name
FDA lists 169 510(k) clearances under 3 spellings of the applicant name “W. L. Gore & Associates, Inc.” (first 1980, latest 2025), plus 13 PMA decisions, across 56 product codes in 12 review panels. Median 510(k) review time under this name: 84 days. Since 2017 the median was 85 days, against 115 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 4 | 66 |
| 2013 | 2 | 81 |
| 2014 | 1 | 279 |
| 2015 | 2 | 57 |
| 2016 | 1 | 101 |
| 2017 | 3 | 86 |
| 2018 | 4 | 162 |
| 2019 | 1 | 29 |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 1 | 84 |
| 2023 | 2 | 38 |
| 2024 | 2 | 105 |
| 2025 | 1 | 109 |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name W. L. Gore & Associates, Inc. took a median 85 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 115 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| FTL | Mesh, Surgical, Polymeric | 37 | 37 |
| DSY | Prosthesis, Vascular Graft, Of 6mm And Greater Diameter | 24 | 24 |
| DXZ | Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene | 13 | 13 |
| DYF | Prosthesis, Vascular Graft, Of Less Then 6mm Diameter | 8 | 8 |
| DYB | Introducer, Catheter | 7 | 7 |
| LYC | Bone Grafting Material, Synthetic | 5 | 5 |
| NPK | Barrier, Synthetic, Intraoral | 5 | 5 |
| DQY | Catheter, Percutaneous | 4 | 4 |
| MIH | System, Endovascular Graft, Aortic Aneurysm Treatment | 4 | 0 |
| MOS | Coil, Magnetic Resonance, Specialty | 4 | 4 |
Plus 46 more product codes.
Review panels
- Cardiovascular (79)
- General and Plastic Surgery (59)
- Dental (11)
- Orthopedic (7)
- Gastroenterology and Urology (5)
- General Hospital (5)
- Neurology (5)
- Radiology (4)
- Anesthesiology (3)
- Ear, Nose and Throat (1)
- Immunology (1)
- Ophthalmic (1)
Most recent W. L. Gore & Associates, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K250410 | GORE® Tri-Lobe Balloon Catheter | DQY | 2025-06-02 | 109 |
| K240083 | GORE® PROPATEN® Vascular Graft | DSY | 2024-03-01 | 50 |
| K232312 | GORE® PROPATEN® Vascular Graft | DSY | 2024-01-09 | 160 |
| K233551 | GORE® ACUSEAL Vascular Graft | DSY | 2023-12-19 | 46 |
| K231505 | GORE® ACUSEAL Vascular Graft | DSY | 2023-06-23 | 30 |
| K222919 | GORE® ENFORM Biomaterial | OXF | 2022-12-19 | 84 |
| K191773 | GORE BIO-A Tissue Reinforcement | OWT | 2019-07-31 | 29 |
| K180919 | GORE Tri-Lumen Catheter | DQY | 2018-10-05 | 179 |
| K181940 | GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement | OXC | 2018-08-17 | 29 |
| K173333 | GORE ENFORM Biomaterial | OXF | 2018-04-05 | 164 |
159 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P250017 | PMA | GORE® VIABAHN® FORTEGRA Venous Stent | 2025-12-19 |
| P230023 | PMA | GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis | 2024-01-12 |
| P210032 | PMA | GORE TAG Thoracic Branch Endoprosthesis (TBE Device) | 2022-05-13 |
| P200030 | PMA | Gore Excluder Conformable AAA Endoprosthesis (CEXC) | 2020-12-22 |
| P180010 | PMA | Gore Carotid Stent | 2018-11-01 |
Recalls
32 product recalls in 20 recall events; 11 initiated in the last five years. Most recent: 2026-09-03.
2 product recalls in 1 recall event filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: W L Gore & Assoc, Inc. (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named W. L. Gore & Associates, Inc. is the lead sponsor of 95 device studies on ClinicalTrials.gov (40 active or recruiting). Most recent:
- NCT07480395: Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries. (Not yet recruiting, started 2026-12)
- NCT07564375: MBA Early Feasibility Study (Recruiting, started 2026-09-02)
- NCT07742592: Retrospective Real-World Data Collection of the Conformable GORE® TAG® Thoracic Endoprosthesis When Used in Frozen Elephant Trunk Procedures for Treatment of Aortic Aneurysms and Dissections (Not yet recruiting, started 2026-09-01)
- NCT07691931: TBE Zone 0/1 PMS in Japan (Not yet recruiting, started 2026-09)
- NCT07304102: Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization (Not yet recruiting, started 2026-09)
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under W. L. Gore & Associates, Inc. (a text match, not an official crosswalk):
- C8900 — Magnetic resonance angiography with contrast, abdomen (via MOS)
- C8901 — Magnetic resonance angiography without contrast, abdomen (via MOS)
- C8918 — Magnetic resonance angiography with contrast, pelvis (via MOS)
- C8919 — Magnetic resonance angiography without contrast, pelvis (via MOS)
- C8902 — Magnetic resonance angiography without contrast followed by with contrast, abdomen (via MOS)
FDA spellings included
FDA records this applicant under 3 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- W. L. Gore & Associates, Inc. (175)
- W. L. Gore and Associates, Inc. (4)
- W.L. Gore & Associates (3)
Frequently asked questions
How many FDA 510(k) clearances are listed under W. L. Gore & Associates, Inc.?
FDA lists 169 510(k) clearances under 3 spellings of the applicant name “W. L. Gore & Associates, Inc.” (first 1980, latest 2025), plus 13 PMA decisions, across 56 product codes in 12 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by W. L. Gore & Associates, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name W. L. Gore & Associates, Inc. is 84 days. Since 2017: 85 days, versus 115 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under W. L. Gore & Associates, Inc.?
The most frequent FDA product codes under this applicant name are FTL (Mesh, Surgical, Polymeric, 37); DSY (Prosthesis, Vascular Graft, Of 6mm And Greater Diameter, 24); DXZ (Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene, 13).
Next steps
- See all 169 W. L. Gore & Associates, Inc. clearances with predicates and recalls
- Run predicate analysis for product code FTL, W. L. Gore & Associates, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.